10 X Genomics Inc (TXG)

Nov 24, 2025

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Finviz

Nov 24, 2025

Nov 24, 2025

CEO Saxonov Files To Sell 13,096 Of 10X Genomics Inc [TXG] - TradingView

Nov 24, 2025

Nov 23, 2025

10x Genomics, Inc.Common Stock (NQ: TXG - Markets Financial Content

Nov 23, 2025

Nov 21, 2025

10X Genomics stock hits 52-week high at 17.7 USD By Investing.com - Investing.com India

Nov 21, 2025

Nov 21, 2025

10X Genomics stock hits 52-week high at 17.7 USD - Investing.com

Nov 21, 2025

Nov 20, 2025

Spatial Biology Market Analysis and Forecast, 2025-2035: - GlobeNewswire

Nov 20, 2025

Nov 20, 2025

Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum - Yahoo Finance

Nov 20, 2025

Nov 20, 2025

How 10x Genomics Inc. (1KJ) stock trades pre earnings2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

Nov 20, 2025

Nov 19, 2025

Total liabilities & shareholders' equities of 10x Genomics Inc Class A – HAM:1KJ - TradingView

Nov 19, 2025

Nov 19, 2025

Is 10x Genomics Inc. stock a buy before product launchesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com

Nov 19, 2025

Nov 18, 2025

10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan

Nov 18, 2025

Nov 16, 2025

10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq

Nov 16, 2025

Nov 16, 2025

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN

Nov 16, 2025

Nov 16, 2025

TXG (10x Genomics) Inventory-to-Revenue : 0.44 (As of Sep. 2025) - GuruFocus

Nov 16, 2025

Nov 15, 2025

10x Genomics Announces Chief Legal Officer Retirement - MSN

Nov 15, 2025

Nov 14, 2025

10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360

Nov 14, 2025

Nov 14, 2025

There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st

Nov 14, 2025

Nov 14, 2025

10x Genomics, Inc. Announces Executive Changes, Effective January 1, 2026 - MarketScreener

Nov 14, 2025

Nov 14, 2025

10X Genomics Stock Soars 17.31%, Hits Intraday High of $15.26 - Markets Mojo

Nov 14, 2025

Nov 13, 2025

10x Genomics Inc Class A Earnings and Revenue – HAM:1KJ - TradingView

Nov 13, 2025

Nov 13, 2025

How 10x Genomics Inc. (1KJ) stock valuation compares with sectorChart Signals & Safe Entry Point Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Why 10x Genomics Inc. (1KJ) stock attracts wealthy investorsSell Signal & Verified Stock Trade Ideas - newser.com

Nov 13, 2025

Nov 13, 2025

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - Eastern Progress

Nov 13, 2025

Nov 13, 2025

5 Insightful Analyst Questions From 10x Genomics's Q3 Earnings Call - Finviz

Nov 13, 2025

Nov 12, 2025

10x Genomics, Inc. (TXG) Stock Price Quote Today & Current Price Chart - Capital.com

Nov 12, 2025

Nov 12, 2025

10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq

Nov 11, 2025

Nov 11, 2025

10x Genomics to Participate in the Wolfe Research Healthcare Con - GuruFocus

Nov 11, 2025

Nov 11, 2025

10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Insider Monkey

Nov 11, 2025

Nov 11, 2025

Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance

Nov 11, 2025

Nov 11, 2025

Is 10x Genomics Inc. stock ready for a breakoutWeekly Market Summary & AI Enhanced Trading Signals - newser.com

Nov 11, 2025

Nov 11, 2025

Can a trend reversal in 10x Genomics Inc. lead to recovery2025 Volume Leaders & Real-Time Volume Analysis - newser.com

Nov 11, 2025

Nov 10, 2025

10x Genomics stock hits 52-week high at 17.26 USD - Investing.com

Nov 10, 2025

Nov 10, 2025

10x Genomics, Inc.'s (NASDAQ:TXG) 33% Price Boost Is Out Of Tune With Revenues - 富途牛牛

Nov 10, 2025

Nov 09, 2025

Research Alert: CFRA Keeps Hold Rating On Shares Of 10x Genomics, Inc. - 富途牛牛

Nov 09, 2025

Nov 08, 2025

10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize

Nov 08, 2025

Nov 08, 2025

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Eledon Pharmaceuticals (ELDN) and AMN Healthcare Services (AMN) - The Globe and Mail

Nov 08, 2025

Nov 08, 2025

10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation - simplywall.st

Nov 08, 2025

Nov 08, 2025

10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 08, 2025

Nov 08, 2025

Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq

Nov 08, 2025

Nov 07, 2025

JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq

Nov 07, 2025

Nov 07, 2025

TXG: Canaccord Genuity Raises Price Target for 10x Genomics to $19 | TXG Stock News - GuruFocus

Nov 07, 2025

Nov 07, 2025

GUIDANCE: (TXG) 10x Genomics, Inc. Expects Q4 Revenue Range $154.0M$158.0M - 富途牛牛

Nov 07, 2025

Nov 07, 2025

10x Genomics, Inc. SEC 10-Q Report - TradingView

Nov 07, 2025

Nov 07, 2025

10x Genomics: Q3 Earnings Snapshot - CT Insider

Nov 07, 2025

Nov 07, 2025

Is 10x Genomics Inc. stock supported by strong fundamentalsPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com

Nov 07, 2025

Nov 07, 2025

10x Genomics Inc (TXG) Q3 2025 Earnings Call Highlights: Navigat - GuruFocus

Nov 07, 2025